Freenome raises $254M for blood test for early detection of cancer

The company is one of a trio in the Bay Area that has raised more than $1 billion to deliver just-as-accurate, easier-to-take blood tests that may be able to detect cancer earlier.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks